| __timestamp | Summit Therapeutics Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 15635076 | 293000 |
| Thursday, January 1, 2015 | 23943601 | 1002000 |
| Friday, January 1, 2016 | 23689111 | 888000 |
| Sunday, January 1, 2017 | 41006114 | 19623000 |
| Monday, January 1, 2018 | 51379106 | 30421000 |
| Tuesday, January 1, 2019 | 32705593 | 34794000 |
| Wednesday, January 1, 2020 | 53274000 | 28304000 |
| Friday, January 1, 2021 | 85352000 | 56886000 |
| Saturday, January 1, 2022 | 51999000 | 100894000 |
| Sunday, January 1, 2023 | 59471000 | 159765000 |
Infusing magic into the data realm
In the ever-evolving landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Summit Therapeutics Inc. and Viridian Therapeutics, Inc. have demonstrated contrasting trajectories in their R&D investments.
Summit Therapeutics began 2014 with a modest R&D expenditure, which grew steadily, peaking in 2021 with a 445% increase from their 2014 spending. However, by 2023, their R&D expenses saw a slight decline of 30% from the previous year. In contrast, Viridian Therapeutics started with minimal R&D spending in 2014 but experienced a dramatic surge, culminating in a staggering 545% increase by 2023.
This data not only highlights the dynamic nature of biotech investments but also underscores the strategic priorities of these companies in their pursuit of groundbreaking therapies.
Research and Development Investment: Novo Nordisk A/S vs Summit Therapeutics Inc.
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Summit Therapeutics Inc.
Research and Development Expenses Breakdown: GSK plc vs Viridian Therapeutics, Inc.
Takeda Pharmaceutical Company Limited or Viridian Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Summit Therapeutics Inc. and Madrigal Pharmaceuticals, Inc.
Analyzing R&D Budgets: Summit Therapeutics Inc. vs Corcept Therapeutics Incorporated
Research and Development: Comparing Key Metrics for Summit Therapeutics Inc. and Rhythm Pharmaceuticals, Inc.
R&D Insights: How Summit Therapeutics Inc. and PTC Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Summit Therapeutics Inc. and Travere Therapeutics, Inc.
Lantheus Holdings, Inc. or Viridian Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: MorphoSys AG and Viridian Therapeutics, Inc.
Analyzing R&D Budgets: Mesoblast Limited vs Viridian Therapeutics, Inc.